NIDA seeks to support shared drug-development infrastructure to help academic and biotech researchers repurpose medications for substance use disorders and advance them toward clinical development.
This grant funds research to develop, test, and implement sustainable health interventions that reduce illness and death in Native American communities, building on their knowledge and strengths.
Supports preclinical and clinical research to develop interventions to prevent or treat substance use disorders and overdose, advancing candidates toward regulatory approval or clinical adoption.
Funding available for research on innovative drug and device treatments for mental disorders, substance use, and alcohol use, promoting collaboration between academia and industry through U01 mechanism.
Funding for collaborative research on new treatments for mental disorders, substance use disorders, and alcohol use disorder, emphasizing novel drugs/devices and industry-academic partnerships.
The NIDA Animal Genomics Program aims to identify genetic variants influencing addictive behaviors, SUD stages, associated behaviors, and comorbidities through genomics approaches.